Your search returned 73 results.

Sort
Results
1.
ASCO's approach to a learning health care system in oncology. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23942494
Year: 2013
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 9(3):145-8, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Hauser RS, Hudis CA, Lichter AS, Mann JT, Sledge GW, Swain SM, Yu PM
2.
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
  • Swain, Sandra M
PMID:
  • 36944848
Year: 2023
Citation:
  • Breast Cancer Research & Treatment. 199(2):243-252, 2023 Jun.
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Azar CA, Baez-Diaz L, Bandos H, Bear HD, Boileau JF, Brufsky AM, Geyer CE Jr Hassan S, Magrinat GC, Mamounas EP, Paik S, Rastogi P, Sarwar S, Shibata HR, Suga JM, Swain SM, Tang G, Wolmark N, Yothers G
3.
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. MedStar authors:
  • Swain, Sandra M
PMID:
  • 26545405
Year: 2016
Citation:
  • Cancer Epidemiology, Biomarkers & Prevention. 25(1):51-9, 2016 Jan.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Anderson SJ, Cecchini RS, Costantino JP, Geyer CE Jr, Jeong JH, Lembersky BC, Paterson AH, Rastogi P, Romond EH, Swain SM, Tang G, Wolmark N
4.
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27864694
Year: 2016
Citation:
  • Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK
5.
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24685829
Year: 2014
Citation:
  • Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
6.
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
  • Swain, Sandra M
PMID:
  • 26759246
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
7.
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23475636
Year: 2013
Citation:
  • Oncologist. 18(3):257-64, 2013.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
8.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
  • Swain, Sandra M
PMID:
  • 28398846
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
9.
What currently defines a breast center? Initial data from the national accreditation program for breast centers. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23814526
Year: 2013
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 9(2):e62-70, 2013 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burgin C, Granville T, Kaufman C, Moran MS, Swain S, Winchester DP
10.
Reply to E.J. Moylan et al. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24419136
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Geyer CE Jr, Swain SM, Tang G
11.
Reply to a. Avan et Al. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25870094
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Kiermaier A, Swain S
12.
Treatment of HER2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25970056
Year: 2015
Citation:
  • New England Journal of Medicine. 372(20):1964-5, 2015 May 14.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Letter
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Swain SM
13.
Adjuvant trastuzumab: does time really matter?. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23624497
Year: 2013
Citation:
  • Oncologist. 18(5):490-2, 2013.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Swain SM
14.
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23045540
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Hoffman HJ, Huerta E, LaVerda NL, Levine PH, Patierno SR, Swain S, Young HA
15.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22152853
Year: 2012
Citation:
  • Lancet. 379(9814):432-44, 2012 Feb 4.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC
16.
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23940225
Year: 2013
Citation:
  • Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
17.
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records. MedStar authors:
  • Swain, Sandra M
PMID:
  • 37167571
Year: 2023
Citation:
  • JCO Oncology Practice. 19(7):435-445, 2023 07.
Institution:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Dang CT, Du Toit Y, Hurvitz SA, Knott A, Polito L, Restuccia E, Sanglier T, Shim J, Swain SM
18.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27693116
Year: 2017
Citation:
  • Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
19.
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24885258
Year: 2014
Citation:
  • BMC Cancer. 14:307, 2014.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
20.
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27812689
Year: 2017
Citation:
  • JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
21.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 26272770
Year: 2015
Citation:
  • Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
22.
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25332247
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
23.
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22393101
Year: 2012
Citation:
  • Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
24.
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24262440
Year: 2013
Citation:
  • Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
25.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25693012
Year: 2015
Citation:
  • New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
26.
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24869931
Year: 2014
Citation:
  • Oncologist. 19(7):693-701, 2014 Jul.
Institution:
  • Washington Cancer Institute
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM
27.
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25559813
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
28.
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27692565
Year: 2017
Citation:
  • Clinical Breast Cancer. 17(1):76-78, 2017 Feb
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Gao JJ, Pohlmann PR, Swain SM, Tan M
29.
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors:
  • Swain, Sandra M
PMID:
  • 32371537
Year: 2020
Citation:
  • Clinical Cancer Research. 26(16):4233-4241, 2020 08 15.
Institution:
  • MedStar Health
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N
30.
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23969513
Year: 2013
Citation:
  • Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
31.
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23685835
Year: 2013
Citation:
  • Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
32.
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23634285
Year: 2013
Citation:
  • Cancer Medicine. 2(2):178-84, 2013 Apr.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Intramural
Form of publication:
  • Journal Article
All authors:
  • Ayed FB, Ayoub WB, Brown LM, Eissa S, Gail M, Kantor ED, Khalafallah S, Khaled H, Merajver S, Omar S, Schairer C, Soliman AS, Swain SM
33.
Health policy: Upholding the Affordable Care Act--implications for oncology. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22869329
Year: 2012
Citation:
  • Nature Reviews Clinical Oncology. 9(9):491-2, 2012 Sep.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • News
Form of publication:
  • Journal Article
All authors:
  • Hudis C, Swain S
34.
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22704583
Year: 2012
Citation:
  • Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
35.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25332249
Year: 2014
Citation:
  • Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
36.
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22694825
Year: 2012
Citation:
  • Clinical Breast Cancer. 12(4):232-9, 2012 Aug.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, Non-P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Duong QN, Hewitt SM, Hoffman HJ, Levine PH, Portera CC, Swain SM, Takikita M, Yang SX
37.
Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 26982349
Year: 2016
Citation:
  • Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Gao J, Swain SM
38.
Twenty-five year results of the national cancer institute randomized breast conservation trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22113254
Year: 2012
Citation:
  • Breast Cancer Research & Treatment. 132(1):197-203, 2012 Feb.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Camphausen K, Dan T, Danforth DN, Glatstein E, Lippman ME, Lita E, Sciuto L, Shih J, Simone NL, Smith SL, Swain SM
39.
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 24529560
Year: 2014
Citation:
  • Lancet. 384(9938):164-72, 2014 Jul 12.
Medline publication type:
  • Journal Article
  • Meta-Analysis
  • Research Support, U.S. Gov't, P.H.S.
  • Review
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Bergh J, Blohmer J, Blumenthal G, Bogaerts J, Bonnefoi H, Cameron D, Cortazar P, Costantino JP, Ditsch N, Eidtmann H, Eiermann W, Fasching PA, Gerber B, Geyer CE Jr, Gianni L, Justice R, Loibl S, Mamounas EP, Mehta K, Paik S, Pazdur R, Perou C, Piccart M, Prowell T, Rastogi P, Semiglazov V, Slaets L, Sridhara R, Swain SM, Tang S, Untch M, Valagussa P, von Minckwitz G, Wickerham DL, Wolmark N, Zhang L
40.
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 23530718
Year: 2013
Citation:
  • Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • O'Sullivan CC, Swain SM
41.
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
  • Swain, Sandra M
PMID:
  • 25542269
Year: 2015
Citation:
  • Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
42.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23602601
Year: 2013
Citation:
  • Lancet Oncology. 14(6):461-71, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
43.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22276821
Year: 2012
Citation:
  • New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
44.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 34890214
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
45.
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24095300
Year: 2013
Citation:
  • Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
46.
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 22233389
Year: 2012
Citation:
  • Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Review
Form of publication:
  • Journal Article
All authors:
  • Amiri-Kordestani L, Swain SM, Tan AR
47.
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. [Review] MedStar authors:
  • Swain, Sandra M
PMID:
  • 35430509
Year: 2022
Citation:
  • Cancer Treatment Reviews. 106:102378, 2022 May.
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Andre F, Bartholmai BJ, Conte P, Kato T, Lancaster LH, Li BT, Naidoo J, Nicholson AG, Nishino M, Powell CA, Schumacher-Wulf E, Shitara K, Swain SM, Tsurutani J
48.
Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?. MedStar authors:
  • Barac, Ana
  • Swain, Sandra M
PMID:
  • 27356170
Year: 2016
Citation:
  • JAMA Oncology. 2(8):1037-9, 2016 Aug 01
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Swain SM
49.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24930388
Year: 2014
Citation:
  • Cancer. 120(17):2657-64, 2014 Sep 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
50.
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
  • Swain, Sandra M
PMID:
  • 24129974
Year: 2013
Citation:
  • Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
51.
Building bridges to conquer cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24043734
Year: 2013
Citation:
  • Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Addresses
  • Congresses
Form of publication:
  • Journal Article
All authors:
  • Swain SM
52.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23868905
Year: 2013
Citation:
  • Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
53.
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 24921704
Year: 2014
Citation:
  • Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • Lynce F, Swain SM
54.
Pertuzumab: increasing the options. MedStar authors:
  • Nunes, Raquel
  • Swain, Sandra M
PMID:
  • 24855727
Citation:
  • Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comment
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Nunes R, Swain SM
55.
Avastin withdrawal symptoms. MedStar authors:
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 22263961
Citation:
  • Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Editorial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Lynce F, Swain SM
56.
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age. MedStar authors:
  • Nunes, Raquel
  • Swain, Sandra M
PMID:
  • 26610382
Year: 2015
Citation:
  • Advances in Therapy. 32(12):1222-36, 2015 Dec.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Nunes R, Rothney M, Sing AP, Swain SM, Yoshizawa C
57.
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
  • Smith, D Max
  • Swain, Sandra M
PMID:
  • 36821823
Year: 2023
Citation:
  • Journal of Clinical Oncology. 41(15):2701-2705, 2023 May 20.
Department:
  • Associate Dean for Research Development
  • MedStar Health
  • Pharmacogenomics
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
58.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
  • Swain, Sandra M
  • Zapas, John L
PMID:
  • 29072977
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
59.
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
  • McCarron, Edward C
  • Swain, Sandra M
PMID:
  • 28954297
Year: 2018
Citation:
  • Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
  • MedStar Franklin Square Medical Center
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
60.
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. MedStar authors:
  • Smith, D Max
  • Swain, Sandra M
PMID:
  • 34562070
Year: 2022
Citation:
  • Clinical and translational science. 15(2):371-383, 2022 02.
Department:
  • Associate Dean for Research Development
  • MedStar Health
  • Pharmacogenomics
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, IGNITE Pharmacogenetics Working Group, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
61.
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives. MedStar authors:
  • Bhatt, Meghna
  • Kazi, Sadaf
  • Smith, D Max
  • Swain, Sandra M
PMID:
  • 37942634
Year: 2023
Citation:
  • Pharmacogenomics. 24(16):859-870, 2023 Nov.
Institution:
  • MedStar Institute for Innovation
  • MedStar Washington Hospital Center
Department:
  • Associate Dean for Research Development
  • MedStar Health
  • National Center for Human Factors in Healthcare
  • Pharmacogenomics
  • Pharmacy Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bhatt M, Peshkin BN, Kazi S, Schwartz MD, Ashai N, Swain SM, Smith DM
62.
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. MedStar authors:
  • Banda, Deliya R
  • Libin, Alexander V
  • Swain, Sandra M
  • Wang, Hong
PMID:
  • 22639112
Year: 2012
Citation:
  • Oncologist. 17(5):708-14, 2012.
Institution:
  • MedStar Health Research Institute
  • MedStar National Rehabilitation Network
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Banda DR, Libin AV, Swain SM, Wang H
63.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
64.
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. MedStar authors:
  • Kurian, Shweta
  • Mohebtash, Mahsa
  • Ottaviano, Yvonne
  • Rao, Suman
  • Swain, Sandra M
PMID:
  • 36280642
Year: 2022
Citation:
  • Breast Cancer Research & Treatment. 196(3):571-581, 2022 Dec.
Institution:
  • MedStar Franklin Square Medical Center
Department:
  • Associate Dean for Research Development
  • Hematology/Oncology
  • MedStar Health
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Dilawari A, Graham D, Isaacs C, Kurian S, Lynce F, Mainor C, McNamara D, Mohebtash M, Ottaviano Y, Pohlmann PR, Rao S, Swain SM, Swanson N, Tan M, Warren R, Wu T
65.
Take care of your neighborhood. MedStar authors:
  • Huerta, Elmer E
  • Swain, Sandra M
  • Weeks-Coulthurst, Patricia
  • Williams, Courtney
PMID:
  • 28900788
Year: 2018
Citation:
  • Breast Cancer Research & Treatment. 167(1):225-234, 2018 01.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Huerta EE, Swain SM, Weeks-Coulthurst P, Williams C
66.
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system. MedStar authors:
  • Hui, Adrian C
  • Lee, Andrew J
  • Smith, D Max
  • Swain, Sandra M
  • Walker, Alexander
PMID:
  • 35042388
Year: 2022
Citation:
  • Pharmacogenomics. 23(3):173-182, 2022 02.
Institution:
  • MedStar Institute for Innovation
  • MedStar Union Memorial Hospital
Department:
  • Associate Dean for Research Development
  • MedStar Health
  • Pharmacogenomics
  • Pharmacy
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Hui AC, Lee AJ, Peshkin BN, Smith DM, Swain SM, Walker AD
67.
Genomic profiling of breast cancer in African-American women using MammaPrint. MedStar authors:
  • Boisvert, Marc E
  • Herbolsheimer, Pia M
  • Mete, Mihriye
  • Nunes, Raquel
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 27568021
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 159(3):481-8, 2016 Oct
Institution:
  • MedStar Health Research Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bijelic L, Boisvert ME, Herbolsheimer P, Mete M, Nunes RA, Smith KL, Swain SM, Wray L
68.
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Cunningham, A
  • Gallagher, Christopher
  • Hofmeyer, Mark
  • Srichai, M B
  • Swain, Sandra M
PMID:
  • 30852761
Year: 2019
Citation:
  • Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
  • MedStar Health
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
69.
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
  • Herbolsheimer, Pia M
  • Jelinek, James S
  • Kapoor, R
  • Perry, David J
  • Smith, Karen L
  • Swain, Sandra M
  • Verma, Nitin
  • Veytsman, Irina
PMID:
  • 22392508
Citation:
  • Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Radiology
Medline publication type:
  • Clinical Trial, Phase I
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
70.
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Herbolsheimer, Pia M
  • Lynce, Filipa
  • Mete, Mihriye
  • Nunes, Raquel
  • Shara, Nawar M
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 26749359
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
  • Washington Cancer Institute
  • Washington Cancer Institute A
  • Washington Cancer Instituteia
Department:
  • MedStar Heart Institute
  • MedStar Heart Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
71.
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing. MedStar authors:
  • Brandt, Nicole
  • Brown, Ryan P
  • Levin, Bonnie
  • Smith, D Max
  • Swain, Sandra M
  • Walsh, Richard J
  • Welsh, James C
PMID:
  • 32969759
Year: 2020
Citation:
  • Pharmacogenomics. 21(15):1085-1094, 2020 10.
Institution:
  • MedStar Medical Group
Department:
  • Assistant Vice President
  • Associate Dean for Research Development
  • MedStar Center for Successful Aging
  • MedStar Health
  • Pharmacogenomics
  • Vice President
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brandt N, Brown RP, Levin B, Namvar T, Peshkin BN, Smith DM, Springfield TB, Swain SM, Walsh RJ, Welsh JC
72.
Improving Documentation of Pain Management at MedStar Washington Cancer Institute. MedStar authors:
  • Agrawal, Sundeep
  • Beasley, Janet
  • Chokshi, Puja
  • Harkness, Jaylon
  • Heller, Stephanie
  • Jang, Sekwon
  • Ranpura, Vishal
  • Self, Linda
  • Swain, Sandra M
  • Wood, Lynne
  • Yerasi, Charan
PMID:
  • 25690597
Year: 2015
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 11(2):155-7, 2015 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Agrawal S, Beasley J, Chokshi P, Harkness J, Heller S, Jang S, Ranpura V, Self L, Swain SM, Wood L, Yerasi C
73.
Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings. MedStar authors:
  • Brown, Ryan P
  • Eldadah, Zayd A
  • Hwang, Elizabeth
  • Kmiecik, Susanna
  • Levin, Bonnie
  • Lundergan, Conor
  • McAlduff, Joel
  • Shapiro, Richard
  • Smith, D Max
  • Swain, Sandra M
PMID:
  • 31961467
Year: 2020
Citation:
  • Clinical and translational science. 13(3):618-627, 2020 05.
Institution:
  • MedStar Health
  • MedStar Heart & Vascular Institute
  • MedStar Union Memorial Hospital
  • MedStar Washington Hospital Center
  • SiTEL
Department:
  • Anesthesiology
  • Associate Dean for Research Development
  • Chief Medical Information Officer
  • Pharmacogenomics
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brown RP, Eldadah Z, Hwang E, Kmiecik S, Levin B, Lundergan C, McAlduff J, Peshkin BN, Shapiro R, Smith DM, Springfield TB, Swain SM
Pages

Powered by Koha